Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cystic Fibrosis: Successes, Opportunities And Challenges

Feb 22 2017

• By Lucie Ellis-Taitt

IV1702_CysticFibrosis_Feature_1200

Related Content

With Incivek Deflated, Vertex’s HCV Roller Coaster Ride Hinges On Phase II Candidate VX-135

Oct 29 2013

Australian Kalydeco decision 'deferred,' patients will fight but need a champion

Aug 30 2013

Australia thrashes out patient access deals for Soliris/Kalydeco

Oct 31 2014

Moderna Signs Single Drug Deal With CF Expert Vertex For Up To $315m

Jul 07 2016

Related Companies

Vertex Pharmaceuticals Incorporated

AbbVie Inc.

Roche Holding AG

Novartis AG

Gilead Sciences, Inc.

Bristol Myers Squibb Company

Galapagos NV

Sanofi

AstraZeneca PLC

Editas Medicine

Moderna, Inc.

Insmed Incorporated

Bayer AG

Horizon Therapeutics plc

PTC Therapeutics, Inc.

Takeda Pharmaceutical Co. Ltd.

Proteostasis Therapeutics, Inc.

Pulmatrix, Inc.

Corbus Pharmaceuticals Holdings, Inc.

Liminal BioSciences Inc.

Savara Inc.

Additional Topics

Growth Clinical Trials BioPharmaceutical Respiratory

More from Growth

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window